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http://dx.doi.org/10.1016/j.str.2016.10.011SUMMARY
The causative agent of toxoplasmosis, the intracel-
lular parasite Toxoplasma gondii, delivers a protein,
GRA24, into the cells it infects that interacts with
the mitogen-activated protein (MAP) kinase p38a
(MAPK14), leading to activation and nuclear translo-
cation of the host kinase and a subsequent inflam-
matory response that controls the progress of the
parasite. The purification of a recombinant complex
of GRA24 and human p38a has allowed the molecu-
lar basis of this activation to be determined. GRA24 is
shown to be intrinsically disordered, binding two ki-
nases that act independently, and is the only factor
required to bypass the canonical mitogen-activated
protein kinase activation pathway. An adapted ki-
nase interaction motif (KIM) forms a highly stable
complex that competes with cytoplasmic regula-
tory partners. In addition, the recombinant complex
forms a powerful in vitro tool to evaluate the speci-
ficity and effectiveness of p38a inhibitors that have
advanced to clinical trials, as it provides a hitherto
unavailable stable and highly active form of p38a.
INTRODUCTION
A critical issue for the immune system in mammals is to achieve
a balance between protection and immune pathology. Much
research has focused on the regulatory mechanisms of this bal-
ance and their dysfunction in a number of disease settings. In the
specific setting of host infection and intracellular pathogens, it
has been found that a wide range of pathogens directly hijack
the immunoregulatory network during the course of infection.
In the case of the Apicomplexa protozoan Toxoplasma gondii,
the parasite has evolved methods to trigger a transient innate
proinflammatory response that guarantees both control of the
parasite population and survival of the host, promoting the16 Structure 25, 16–26, January 3, 2017 ª 2016 The Authors. Publish
This is an open access article under the CC BY-NC-ND license (http://establishment of a persistent cryptic parasite population (i.e.,
parasite survival) (Hunter and Sibley, 2012). Like most patho-
gens, it has evolved numerous methods of hijacking cell-
signaling pathways in order to survive in the host cell. As an
obligate intracellular protozoan, it delivers effector proteins into
its host cell (Hakimi and Bougdour, 2015; Melo et al., 2011) to
control mitogen-activated protein kinase (MAPK) signaling in
macrophages, which in turn dictate parasite burden and disease
(Braun et al., 2013; Kim et al., 2005). MAPK signaling is char-
acterized by a cascade of multiple kinases, through which the
signal is transduced in the form of phosphorylation events from
an upstream kinase to a downstream one (Chen et al., 2001;
Johnson and Lapadat, 2002). The final phosphorylation event
is a dual phosphorylation, which occurs on a conserved Thr-
X-Tyr motif in the activation loop (AL) of the MAPK (Cobb and
Goldsmith, 1995; Davis, 1995). The phospho-residues are then
able to bind basic patches, changing the relative orientation
from open in the inactive state to closed in the active state allow-
ing nucleotide binding in the active site (Jura et al., 2011; Kornev
and Taylor, 2010).
One of the effector proteins secreted by T. gondii, GRA24, has
been shown to interact with the MAP kinase p38a, promoting its
activation and nuclear translocation (Braun et al., 2013). GRA24
encodes a 542 amino acid protein with an internal putative
bipartite nuclear localization signal, and two repeats, R1 and
R2, at the C terminus (Figure 1A). The mechanism by which
GRA24 activates p38a, either directly or by modulating the exist-
ing activation pathway, is unknown. Previous experiments that
mapped the region of the interactions between the two proteins
in infected cells show that only one of the repeats is essential
for the activation of p38a. Through a docking model, it was pro-
posed that binding of p38a by GRA24 is driven by the kinase
interaction motif (KIM), embedded in each of the two repeat re-
gions (Figure 1A). KIMs are linear motifs used by kinases, phos-
phatases, substrates, and scaffold proteins to bind MAPKs at
the KIM or D-motif binding site and regulate their activity (Enslen
et al., 2000; Kallunki et al., 1996; Zuniga et al., 1999). KIMs
ensure specificity between partners but also have allosteric ef-
fects on the proteins (De Nicola et al., 2013; Tokunaga et al.,
2014; Zhou et al., 2006).ed by Elsevier Ltd.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Structure of the GRA24KIM1-p38a
Complex
(A) Diagram of GRA24, KIM deletion mutants, and
N-terminally truncated constructs used in this
study. Signal peptide (red), nuclear localization
signal (blue), internal repeats (purple), and KIM
(yellow) sequences are shown.
(B) The structure of p38a is shown as a solvent
accessible surface colored by electrostatic po-
tential (10 to 10 kTe1, red to blue) and the
GRA24KIM1 peptide is shown in cartoon repre-
sentation with side chains as sticks (yellow). Details
of the interactions between p38a and GRA24KIM1
are inset. GRA24 uses all the classical interac-
tions (ɸA, ɸB, ɸL, ɸU, andRR) aswell as an additional
hydrophobic interaction with V447.
(C) Conformational changes induced by GRA24-
KIM1 binding allow nucleotide entry to the active
site (inactive conformation PDB: 5ETC, active
conformation PDB: 1CM8). The rearrangement of
the C-spine (Val38, Ala51, Ala157, Leu156, Val158,
Leu113, Ile212, and Leu216) from the inactive to
active state is highlighted by the movement of
Val38.Here, we have produced a recombinant complex of anN-termi-
nal truncation of GRA24 (GRA24DN, Figure 1A) and p38a. Using
a combinatorial approach of various structural techniques, the
macrostructure of the recombinant complex between GRA24
and p38a and the crystal structure of the core interaction between
the proteins is described. The results provide a molecular view of
activation and define GRA24 as the only component required
to activate p38a. The recombinant complex of GRA24 and p38a
also provides a highly specific tool to determine the activity of
p38a inhibitors that have advanced to clinical trials.
RESULTS
Structure of the GRA24KIM1-p38a Complex
To define the molecular basis of the interaction between p38a
and GRA24, we determined the crystal structure of p38a bound
to the GRA24 KIM1 peptide (residues 440–455) at 2.8 A˚ (Table 1).
The complex crystallized in the triclinic space group P1 with two
molecules in the asymmetric unit. The electron density for the
GRA24KIM1-p38a complex was excellent and the entire peptide
sequence could be traced (Figure S1A). As the density is slightly
better in the second molecule (chain B), only this chain is used insubsequent descriptions. KIMs have a
general consensus sequence of X-fU-
X2-(q(Arg/Lys))1-2-(X)2-6-fL-(X)1-2-fA-X-fB
(where fA, fB, fL, and fU are hydropho-
bic residues [usually Leu, Ile, or Val] and
q is a basic residue [Arg or Lys]) (Gavin
and Nebreda, 1999; Smith et al., 1999),
shorter motifs can lack the first four resi-
dues (Sharrocks et al., 2000; Zeke et al.,
2015). The KIM or D-motif binding site is
formed by an acidic patch known as the
common docking (CD) domain (Tanoue
et al., 2001) and a hydrophobic dockinggroove (Chang et al., 2002; Gum and Young, 1999) (Figure 1B).
The CD domain accommodates thefU and basic residues, while
the hydrophobic docking groove binds fA, fB, and fL (Akella
et al., 2010; Heo et al., 2004; Lee et al., 2006). The GRA24 pep-
tide binds with the hydrophobic residues (FA-FB) in the docking
groove formed by ad and ae and the reverse turn between b7 and
b8 in the C-terminal lobe of p38a (Figure 1B). Moreover, GRA24
utilizes all interacting motifs identified so far (Peti and Page,
2013; Zeke et al., 2015), including the additional hydrophobic
residues, FL and FU, and the ionic contacts with the p38a CD
domain, where the KIM1 peptide forms a short a helix involving
residues RRELLG (Figure 1B). An additional hydrophobic inter-
action, not observed in other KIMs, is made with V447. Binding
of GRA24KIM1 causes significant conformational change and
disorder in the AL with a rotation of the N-terminal domain of
10 toward the C-terminal domain caused by tightening between
the areas linked by the peptide (Figure 1C). This movement re-
sults in the alignment of the catalytic spine (C-spine) toward
the active state, one of the essential events in kinase activation
(McClendon et al., 2014), the residues belonging to the C-spine
and the hinge region are in a similar position to the fully acti-
vated ATP bound p38g (Bellon et al., 1999) (Figure 1C). TheStructure 25, 16–26, January 3, 2017 17
Table 1. Data Processing and Refinement Statistics for the
GRA24KIM1-p38a and MKK6KIM-p38aK53R Structures
Structure
GRA24KIM-p38a
(5ETA)
MKK6KIM-p38aK53R
(5ETF)
Data Collection
Space group P1 P3121
Unit cell dimensions
a, b, c (A˚) 52.0, 61.9, 75.7 82.4, 82.4, 123.3
a, b, g () 105.6, 96.3, 114.7 90.0, 90.0, 120.0
Resolution range (A˚) 45.79 (2.95–2.8) 46.65 (2.49–2.4)
Rmeas 0.09 (0.27) 0.108 (0.690)
<I/s(I)> 9.9 (3.0) 13.3 (2.1)
Redundancy 1.9 (1.9) 3.9 (3.9)
Completeness (%) 96.5 (97.2) 90.3 (59.0)
Refinement
Resolution range (A˚) 20.0 (2.95–2.8) 20.0 (2.49–2.4)
No. of reflections 36,372 32,069
Rwork/Rfree 22.3/28.3 16.29/23.1
No. of atoms
Protein 2,715 (A), 2,705 (B) 2,725
127 (C), 127 (D)
GRA24KIM1
92 (MKK6KIM)
Water 29 223
B factors (A˚2)
Protein 63.69 (A), 59.98 (B) 32.25
Ligand 73.97 (C), 83.91 (D) 42.33
Water 46.87 33.48
RMSD
Bond lengths (A˚) 0.006 0.0078
Bond angles () 1.113 0.931
Ramachandran
favored (%)
95.8 97.7
Ramachandran
outliers (%)
0.4 0
Rotamer outliers (%) 2.2 1.3
Clash score 9.68 4.82
Overall score 2.07 1.41
Values in parentheses are for the outer resolution shell.
RMSD, root-mean-square deviation.rearrangement also leads to a rotation of methionine 109 in
the hinge region that prevents nucleotide binding in the active
site of the inactive protein (Figure 1C). These conformational
changes would allow the entry of ATP into the active site and
make the AL accessible for phosphorylation between activated
p38a molecules.
GRA24 Has High Affinity for p38a by Combining the
Attributes of Different KIM Domains
To further characterize the interaction between GRA24 and
p38a we compared the binding of GRA24 KIM1 with other KIM
peptides described in the literature (Table S1) using isothermal
calorimetry (ITC). The GRA24 KIM1 peptide was found to bind
p38a with an equilibrium dissociation constant (KD) of 1.6 mM18 Structure 25, 16–26, January 3, 2017(Table S1 and Figure S2), 2-fold tighter than KIMs found in
phosphatases, which have the highest measured affinity of cyto-
solic regulatory partners involved in classical MAPK regulation
(Francis et al., 2011). While the full-length proteins may show
different affinities and binding modes, these results show that
the GRA24 KIM has a higher affinity than either upstream kinases
or downstream phosphatase KIMs.
The GRA24KIM1-p38a structure shows that high-affinity and
allosteric effects (disorder of the AL) is achieved by combining
the sequences of both the upstream MKK KIMs and those of the
downstreamphosphatases (Figures 2B, 2C, andS3). To compare
binding by an upstream kinase we determined a complex of a
kinase dead mutant and the KIM domain from MKK6 (residues
4–18) at 2.4 A˚ (MKK6KIM-p38aK53R, Table 1) with no mutation
in the KIM binding area, as there is in a published structure
(C162S) (Garai et al., 2012). The complex crystallized in the
trigonal P3121 space group with one molecule in the asymmetric
unit. Comparison of the structures shows GRA24 binding in a
similar manner to the hydrophobic groove, using the same L and
I residues forFA-FB but, unusually, uses the hydrophobic base of
arginine in the FL pocket (Figure 2C). This is a longer linker be-
tween FL and FB pockets than predicted and is more similar to
theGRA24KIM that has a double proline spacer. There is no inter-
action with the CDdomain or the associated secondary structural
rearrangement (FigureS1B).None of theMAPKK-p38a structures
available show binding to the CD domain. However, GRA24KIM1
binding to thep38aCDdomain is similar to that described for tyro-
sine phosphatases (Figure 2B), the KIMsofwhich comprise anRR
motif usually structured in a short a helix (Zhou et al., 2006).
The only KIM with a higher affinity for p38a is from the MAPK
substrate MAPKAP kinase 2 (KD of 50 nM; Garai et al., 2012).
As MAPKAPK2 is only present in the nucleus (Zakowski et al.,
2004) it will not compete with recruitment of p38a by GRA24
in the cytoplasm. Nevertheless, it is interesting to note that the
GRA24 KIM1 has a very similar mode of binding to theMAPKAP2
KIM, both in the hydrophobic groove and to the CD domain,
leading to very tight binding (Figure 2E). The major difference be-
tween the two KIMs is the reverse direction of the MAPKAP2
sequence (Figure S3, C- to N-terminal) and increased secondary
structure elements (Figure 2E).
The Structure of the GRA24DN-p38a Complex Shows
Two Independent Kinases Bound to an Intrinsically
Disordered Protein
To define the mechanism of activation of p38a by GRA24 the
complex between the proteins must be studied; we therefore
attempted to produce the protein in Escherichia coli. Expression
of either the wild-type (WT) or a truncation removing the N termi-
nus to the nuclear localization sequence (GRA24DN, residues
337–542, Figure 1A) failed to produce detectable expression.
However, when co-expressed with p38a, a stable complex be-
tween p38a and GRA24DN was produced (Figure S4) as the
association with the kinase presumably prevents proteolysis.
The complex was purified to homogeneity and analysis of
staining intensity indicated a ratio of 1:2 for GRA24DN to p38a.
We then investigated the structure of the complex using small-
angle X-ray scattering (SAXS). SAXS was used to determine
the average structure of the GRA24DN-p38a complex in solution
(Table S2). The radius of gyration was determined to be 4.85 nm
Figure 2. Comparison of the Binding Modes
of KIMs
(A) The GRA24 KIM. Residues that interact directly
are shown as sticks.
(B) Comparison with the phosphatase PTP KIM,
GRA24, and the PTP KIM have a very similar
binding to the CD domain with the ɸU and RR
residues but diverge as the hydrophobic groove is
approached.
(C) Comparison with the p38-activating kinase
MKK6 KIM: similar binding is observed in the hy-
drophobic groove with a larger space between the
ɸB and ɸL pockets.
(D) Comparisonwith the yeastMAPKsubstrate Far1
KIM, a very similar mode of binding is observed that
only diverges at the CD domain.
(E) Comparison with the p38 substrate MAPKAP2
KIM that has the highest affinity and runs C- to
N-terminal left to right. The interactions are very
similar despite the additional secondary structure
and reverse binding.
(F) Comparison with the yeast Ste7 KIM. The two
KIMs are very similar in sequence but binding di-
verges slightly at the CD domain. See also Figures
S3 and S5.with a Dmax of 16.96 nm and ab initio modeling showing an elon-
gated molecule (Figures 3A and 3B) best described by a disor-
dered protein binding two globular domains. The pair distribution
function (Figure 3A, inset) also suggests flexibility between the
kinases (full width at half maximum of 3.8–6.2 nm about the
mode of 4.85 nm) implying disorder in GRA24. The possibility
that the dimer observed in the crystal structure could also be
present in solution was tested by SAXS (Table S2) and found
to be a crystallization artifact.
Using the crystal structure of the GRA24KIM1-p38a complex
and modeling GRA24 as an intrinsically disordered protein, a
structure of the complex can be proposed (Figures 3B and
3C). The refined model is an excellent fit to the experimental
curve (c2 = 1.08) and provides insight into its mode of action (Fig-
ures 3A–3C). The two kinases are bound at the C terminus of
GRA24, linked by 65 residues.
Dimerization has been demonstrated to be part of an acti-
vating mechanism for p38a and its close homolog ERK2 (Diskin
et al., 2007; Khokhlatchev et al., 1998). The presence of two
KIMs in GRA24 opens the possibility that dimerization between
the bound kinases could play a role in activation. The SAXS
data imply movement between the kinases; however, as it only
provides an average envelope of the structure the relationshipbetween the kinases cannot be fully
defined. We therefore used single-mole-
cule approaches, negative-stain electron
microscopy (EM), and atomic force
microscopy (AFM), to investigate the dy-
namics of the complex. EM confirmed
the flexibility, with class averages showing
the two kinases in close proximity, but with
a considerable variety of positions (Fig-
ure 3D). AFM also shows the dynamic
nature of the complex at the single-mole-cule level (Figure 3E). In both AFM and EM data no secondary
structure can be observed in GRA24 confirming its disordered
nature. These data demonstrate flexibility between the kinases,
eliminating the possibility of a dimer, which implies that the ki-
nases can act independently.
We therefore tested the requirement in vivo of each of the KIMs
specifically, by developing 293 derived inducible stable cell lines
expressing hemagglutinin (HA) Flag-tagged GRA24 where either
KIM1, KIM2, or both KIMs were mutated to alanine (Figure 1A).
Immunoblotting for phosphorylated p38a demonstrates that
GRA24 induces phosphorylation with only one KIM, but at least
one is required for activity as the double mutant leads to an
absence of activated p38a (Figure 4A). This is in agreement
with previous results demonstrating that a single internal repeat
domain was required for activation (Braun et al., 2013). This
result defines the GRA24-KIM as the essential factor in the
recruitment and activation of p38a in vivo and that dimerization
of the kinases is not required for activation.
The Recombinant Complex Is Active and Provides a Tool
to Assess p38a Inhibitors
The activity of the complex was assessed by assaying its ability
to phosphorylate itself (Figure 4B) and also a typical transcriptionStructure 25, 16–26, January 3, 2017 19
Figure 3. Structure of the GRA24DN-p38a Complex
(A) Scattering curve of the GRA24DN-p38a complex: the fit of models (B) and (C) is shown in blue and the pair distribution function is shown in the inset.
(B) Ab initio model of the GRA24DN-p38a complex (blue mesh) with the final model (internal repeats, purple; KIM, yellow; p38a is shown with N-terminal lobes in
gray, C-terminal in green, and AL in blue).
(C) Model of the GRA24DN-p38a complex, colored as in (B), in stereo showing phosphorylation sites (magenta) identified bymass spectrometry (Table S3) scaled
according to the number of times found.
(D) Class averages from negative-stain EM of the GRA24DN-p38a complex. Arrows indicate class averages where the two p38a molecules are separated;
considerable variety in the orientation of the two kinases is observed. The SAXS model is shown to scale for reference.
(E) The GRA24DN-p38a complex visualized by AFM, kinase pairs are observed in multiple conformations.factor target of p38a, activating transcription factor 2 (ATF2) (Fig-
ure 4C). Incubation of the complex with radiolabeled ATP dem-
onstrates the complex is active (Figure 4B) and mass spectrom-
etry shows that phosphorylation occurs on multiple serine and
threonine residues within GRA24 (Table S3, Figure 3C), including
a previously identified kinase motif (Braun et al., 2013). Assaying
the complex’s activity against a natural target, ATF2, shows that
p38a in complex with GRA24DN is significantly more active
against ATF2 than p38a alone (Figure 4C). As both proteins
were expressed in E. coli, devoid of endogenous protein kinases,
this defines GRA24DN as the only factor required to activate20 Structure 25, 16–26, January 3, 2017p38a and demonstrates that the complex is a powerful tool
to unambiguously evaluate the pharmacological inhibition of
p38a in vitro. A highly active and stable recombinant form of
p38a is not currently available, hampering efforts to assay the
specific effects of molecules on p38a. Using the GRA24DN-
p38a complex, we have shown that many of the inhibitors devel-
oped against p38a, some of which are currently in phase II
clinical trials, prevent ATF2 phosphorylation by the complex
in vitro (Figure 4C). The ability of the compounds to impair
p38a phosphorylation, in a GRA24-dependent manner, and
concomitant epidermal growth factor 1 (EGR1) activation was
Figure 4. Activity of the GRA24DN-p38a Complex
(A) p38a phosphorylation in 293-TRex cells stably expressing GRA24 WT or KIM mutants. Nuclear fractions were immunoblotted with the indicated antibodies.
Data are representative of three experiments.
(B) Auto-phosporylation of the GRA24DN-p38a complex was analyzed using a radioactivity-based assay, the third lane (Mg*) was treated with l-phosphatase
before the assay.
(C) Analysis of p38aMAP kinase activity by western blot using Phospho-ATF-2 (Thr71) Antibody and its inhibition by known kinase inhibitors. A selection of p38a
inhibitors is shown to have a variety of effects on the inhibition of target phosphorylation. Inhibitors of upstream MKKs and JNK (PD98059 and SP600125) are
shown as controls.
(D) Specific pharmacological inhibition of GRA24-dependent p38a phosphorylation in J774 MØ. Cells infected with WT or Dgra24 KO parasites were incubated
for 18 hr with p38 inhibitors (15 mM), control SAPK/JNK (SP600125, 25 mM), andMKK (PD98059, 15 mM) inhibitors aswell as DMSO vehicle. Nuclear fractionswere
immunoblotted with the indicated antibodies.validated in infectedmacrophages (Figure 4D). Differences in the
observed inhibition between in vivo and in vitro assays, as well
as between different inhibitors (Figures 4C and 4D), demonstrate
the importance of having a permanently active form of p38a.
DISCUSSION
Pathogens often evolve methods of modulating host cell-
signaling pathways in order to promote their growth and persis-
tence in the infected cell. One of the most efficient methods to
interact with host signaling proteins is the use of intrinsically
disordered proteins combined with short linear motifs, as the
evolutionary timescales involved are shorter than those required
for globular domains (Davey et al., 2012; Fuxreiter et al., 2007;
Hagai et al., 2014). Short linear motifs in particular can be used
to allow interactions between a pathogenic protein and that ofa host in a simple manner (Elde and Malik, 2009). This study
demonstrates the molecular basis by which the parasite-derived
agonist GRA24 bypasses the classical MAPK phosphorylation
cascade and induces p38a auto-phosphorylation, forming an
active complex able to activate transcription factors, such as
ATF2.
The parasite protein operates through two atypical KIMs,
embedded in an intrinsically disordered protein, which combine
attributes of docking domains from multiple MAPK partners
to maximize binding. A recent study has analyzed all known
KIMs, identified many novel sequences, and classified them by
their binding modes (Zeke et al., 2015). Differences are defined
in the spacing between hydrophobic residues and the linker be-
tween the CD binding region and the docking groove region.
Intriguingly, the GRA24 KIM borrows attributes from all the
defined classes but does not fit in a single class (Figures 2, S3,Structure 25, 16–26, January 3, 2017 21
Figure 5. Model of How GRA24 Subverts MAP Kinase Signaling
GRA24 is secreted from the parasitophorous vacuole into the host cell
cytoplasm where its high-affinity KIM sequence will recruit p38a. On binding
GRA24, p38a is sequestered from regulatory kinases and phosphatases and
can bind ATP allowing phosphorylation of the activation loop between and
within complexes. The p38a-GRA24 complex is now a highly efficient active
complex that can be translocated to the nucleus allowing a sustained and
regular inflammatory response.and S5). Overall, it is closest to the HePTP class incorporating all
hydrophobic residues as well as the short helix bound to the CD
domain. Interestingly, its linker is the same length as the KIM
from Ste7 (Figure 2F), and its binding mode for the hydrophobic
groove exactly the same as that for Far1 (Figure 2D) with a larger
spacer between the FL and FB pockets (double proline) (Figures
1, 2, S3, and S5). Ste7 and Far1 are an activator and substrate,
respectively, of yeast mating decision MAPKs, and the KIMs
have no known higher eukaryotic equivalent. It is interesting to
note that the binding mode of the GRA24 KIM is most similar
to a unicellular eukaryote interaction pathway. KIMs perform
many roles in the MAP kinase cascade, being present in up-
stream activating kinases, scaffold proteins, and deactivating
phosphatases. Each partner uses the KIM to ensure specificity
and control the protein allosterically. For example, the KIM
from MKK6 loosely associates the two kinases and induces
disorder in the AL making it available for phosphorylation. In
contrast, phosphatase KIMs bind tightly and change the confor-
mation of the AL to present the phospho-residues for dephos-
phorylation (Zhou et al., 2006). The first interaction must be
transient to allow activated p38a to enter the nucleus and act
on substrates, while the second must be long lived in order to
tightly control the signal. On transport of the protein into the
host cytoplasm the GRA24 KIMs will compete with the KIMs
from regulatory pathways and induce conformational changes
that allow ATP binding and the availability of the AL for trans-22 Structure 25, 16–26, January 3, 2017phosphorylation (Figure5). TheGRA24KIM-p38a structure shows
that, in contrast to the so called third conformation of p38a (Akella
et al., 2010) or the conformation induced by TAB1 for cis-phos-
phorylation (De Nicola et al., 2013), the kinase structure is very
close to the active p38a and distinct from the inactive state.
trans-Phosphorylation could occur both between the two kinase
moleculesbound toGRA24andamongkinasesboundbydifferent
GRA24molecules as in vivodatashow thatoneR repeat is enough
to promote p38a auto-phosphorylation (Figure 4). While two
copiesof thekinasearenot necessary for activation, thepossibility
of phosphorylation between GRA24 kinase twins could enhance
activity in a similar manner to scaffolding proteins (Brown and
Sacks, 2009). GRA24 is itself then phosphorylated at multiple
sites. Whether this has functional relevance or is just the result of
an active kinase is not known, but a kinase recognition motif
located between the bound kinases is highly phosphorylated, as
are multiple serine and threonine residues throughout the protein
(Figure 3C). Phosphorylation has been shown to play a role in pro-
tection of proteins from cellular proteases (Desagher et al., 2001;
Døskeland et al., 1996) and also in nuclear translocation (Nardozzi
et al., 2010), which could assist GRA24 in its role. At the N termi-
nus, the rest of the protein is free, exposing the signal sequence
to the nuclear transport machinery and allow the complex to be
imported to the nucleus where it can act on specific transcription
factors (Figure 5) (Braun et al., 2013). The structural features
described here show how high-affinity binding to p38a by
GRA24 prevents deactivation by phosphatases and promotes a
sustained host kinase activation during Toxoplasma infection.
The tight control of the inflammatory signaling prevents either
too weak a response leading to host death or too strong a
response preventing invasion.
Following pathogen infection or tissue damage, p38a induces
the expression ofmultiple genes that together regulate the inflam-
matory response. Therefore, interference in p38a kinase activity
could aid in therapy for inflammatory disorders ranging from
rheumatoid arthritis to chronic obstructive pulmonary disease.
Compounds targeting p38a must be highly selective in order to
avoid adverse side effects triggered byoff-target kinase inhibition.
Although in vitro p38 inhibition assays exist, they are hampered by
the need to activate the MAPK either in vivo, e.g., following lipo-
polysaccharide treatment, or through in vitro MKK6 trans-phos-
phorylation (Szafranska et al., 2005) and the short lived nature of
the activated enzyme. By promoting a long-lasting activation of
p38a, GRA24 challenges the natural-negative-feedback mecha-
nisms that prevent the MAPK activation ad infinitum and offers a
powerful in vitro tool to screen for small-molecule p38a inhibitors.EXPERIMENTAL PROCEDURES
Parasites and Host Cells
Human foreskin fibroblast primary cells, and 293-TRex and J774 cell lines
were cultured in DMEM (Invitrogen) supplemented with 10% heat-inactivated
fetal bovine serum (Invitrogen), 10 mM HEPES buffer (pH 7.2), 2 mM L-gluta-
mine, and 50 mg/mL penicillin and streptomycin (Invitrogen). Cells were incu-
bated at 37C in 5% CO2. The Toxoplasma strains used in this study were
RHku80 WT and RHku80 Dgra24 (Braun et al., 2013).
Reagents
Antibodies against HA (3F10; Roche), p38 MAPK (Cell Signaling Technology),
Phospho-p38 MAPK (Cell Signaling Technology), Phospho-c-Fos (Ser32; Cell
Signaling Technology), H4 Acetylated (EMD Millipore), EGR1 (Cell Signaling
Technology), Phospho-ATF-2 (Thr71; Cell Signaling Technology), and HAUSP
(Bethyl Laboratories) were used in the immunofluorescence assay and/or in
western blotting. Immunofluorescence secondary antibodies were coupled
with Alexa Fluor 488 or Alexa Fluor 594 (Invitrogen). Secondary antibodies
used in western blotting were conjugated to alkaline phosphatase (Promega).
The p38 inhibitors were purchased from InvivoGen and Euromedex.
Cloning, Expression, and Purification
DNA encoding human p38a was synthesized (ShineGene Bio-Technologies)
and cloned into pETBS with an N-terminal His6-tag with a thrombin cleavage
site. The mutant p38aK53R was obtained by PCR-based mutagenesis and
verified by sequencing. Recombinant p38a and p38aK53R were expressed
and purified following the same protocol. Both proteins were expressed in
E. coli BL21 Rosetta2 cells (Novagen/Merck). Cells were lysed in lysis buffer
(50 mM Tris [pH 7.4], 500 mM NaCl, 10 mM MgCl2, 1 mM DTT, 5% glycerol,
and 10 mM imidazole) by mild sonication and the lysate was loaded onto a
pre-packed His trap column (GE Healthcare). Protein was eluted with a linear
gradient to 500 mM imidazole. Cleavage of the His6-tag was performed with
thrombin overnight at 4C in lysis buffer. After separation of cleaved and un-
cleaved protein, samples were further purified by size-exclusion chroma-
tography using a HiLoad 16/60 Superdex 200 pg column (GE Healthcare) in
buffer A (50 mM Tris [pH 7.4], 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, and
5% glycerol). Finally, the protein was loaded onto a Mono Q 5/50 GL (GE
Healthcare) with a gradient to 1 M NaCl. This final step was necessary in order
to separate the mono-phosphorylated protein from unphosphorylated protein.
The protein was then concentrated to 10 mg/mL and stored at 20C.
DNA encoding T. gondii GRA24 N-terminal truncation (GRA24DN) was
synthesized (ShineGene Bio-Technologies) and cloned into pET28a using an
N-terminal His6-tag with a thrombin cleavage site. BL21-CondonPlus(DE3)-
RIL cells transformed with pETBS p38a were then additionally transformed
with pET28a GRA24DN. Co-expression of p38a and GRA24DN was induced
overnight at 18 with 0.2 mM isopropyl-thio-b-D-galactoside. Cells were lysed
in lysis buffer (50 mM Tris [pH 8.0] and 250 mM NaCl) by mild sonication, and
the lysate was loaded onto a pre-packed His trap column (GE Healthcare) in
buffer A (50 mM Tris [pH 8.0], 250 mM NaCl, and 20 mM imidazole). The com-
plex was eluted with a linear gradient to 300mM imidazole. Pure fractions were
pooled and dialyzed against buffer B (50 mM Tris [pH 7.0] and 50 mM NaCl)
overnight and subsequently loaded onto a 5 mL HiTrap Q column (GE Health-
care) and eluted with a gradient to 1 M NaCl where the complex eluted as a
single peak. The complex was then further purified by size-exclusion chroma-
tography using a HiLoad 16/60 Superdex 200 pg column (GE Healthcare) in
buffer C (50 mM Tris [pH 7.4], 50 mM NaCl, and 5% glycerol).
The mutations in GRA24 were introduced in plasmids pcDNA-GRA24
WT-HA-Flag (HF) with the QuikChange Lightning Site-Directed Mutagenesis
Kit (Stratagene). The following oligonucleotides for deletion of KIM sequence
in the backbone vector pcDNA-GRA24 WT-HF vector (Braun et al., 2013)
were used: GRA24del506-515 (50-AGA CTG GTC TTC TTG AGC GCA TCG
TTA AAC CAC C-30), GRA24del506-515-antisense 50-GGT GGT TTA ACG
ATG CGC TCA AGA AGA CCA GTC T-30), GRA24del427-436 (50-GAC TGG
TCT TCT TGA GTA CAT CCC TCG TCC TC-30 ), and GRA24del427-436-
antisense (50-GAG GAC GAG GGA TGT ACT CAA GAA GAC CAG TC-30).
The resulting plasmids were pcDNA-GRA24DKIM1, pcDNA-GRA24DKIM2,
and pcDNA-GRA24DKIM1/DKIM2, respectively.
Isothermal Titration Calorimetry
ITC was performed at 25C using an iTC200 System (MicroCal, GE Health-
care). WT p38a or mutant proteins were dialyzed against the titration buffer
(50 mM Tris [pH 7.0], 50 mM NaCl, and 1 mM DTT). MKK6 and GRA24 KIM
peptides were also prepared in the same buffer. A 70 mM protein solution
was titrated using 26 stepwise injections of 1.5 mL with each of the peptide
solutions placed in the syringe. The GRA24 KIM peptide was used at 0.5 mM
and the MKK6 peptide at 10 mM, the latter due to significantly lower affinity.
The heat generated after each ligand injection was measured on the integral
of the calorimetric signal. The resulting binding isotherms were analyzed by a
nonlinear least-squares fit of the experimental data to a single site model
(Turnbull and Daranas, 2003; Wiseman et al., 1989) using Microcal Origin
7.0 software. Experiments were duplicated and variability estimated to be5% in the binding enthalpy and 10% for both the binding affinity and the
number of sites.
In Vitro Kinase Assay
Auto-phosporylation of the GRA24KIM-p38a complex was analyzed using a
radioactivity-based assay. The complex (1.2 mg) was pretreated with l-phos-
phatase (New England Biolabs) and incubated with 5 mM MgCl2 and 10 mM
ATP (10:1 ATP-gP32) at room temperature. Reactions were run for 30 min
and stopped by adding SDS-PAGE loading buffer. Samples were run on
12% SDS-PAGE and then exposed to film to visualize the extent of incorpora-
tion of P32.
ATF2 Assay
Kinase reactions were performed in the presence of 100 mM ATP and 1 mg of
ATF-2 fusion protein as a substrate. The phosphorylation of ATF-2 at Thr71
was measured by western blot using a Phospho-ATF-2 (Thr71) Antibody.
In Vivo Inhibition Assays
Specific pharmacological inhibition of GRA24-dependent p38a phosphoryla-
tion in J774 MØ was monitored following 18 hr of infection with RHku80 and
RHku80 Dgra24 strains and by using specific p38 inhibitors, control inhibitors,
and DMSO vehicle.
293-TRex Transfection
Twenty-four hours before transfection, cells were plated (80% confluency) in
six-well tissue culture dishes. Flag-fusion protein-expressing plasmids (1 mg)
and 0.1 mg puromycin selection plasmid were co-transfected into 293-TRex
cells with Lipofectamine reagent (Invitrogen) according to the manufacturer’s
instructions. Seventy-two hours later, cells were diluted in the presence of
5 mg/mL puromycin (Sigma-Aldrich) for selection. Individual drug-resistant
clones were expanded and tested for tetracycline-inducible gene expression.
Crystallization
Crystallization conditions were established at the EMBL High Throughput
Crystallization Laboratory (Grenoble, France). To obtain crystals of p38a in
complex with the KIM peptide from GRA24 (GRA24KIM1-p38a) protein was
incubated overnight at 4C with a 3-fold molar excess of peptide GLLERRGV
SELPPLYI (Eurogentec). The complex was then mixed 1:1 with 0.2 M MgCl2,
0.1 M Tris/HCl (pH 8.5), and 25%–28% PEG 3350 and set up in sitting-drop
plates. Crystals were harvested directly from the mother liquor (Pellegrini
et al., 2011) using a MicroMesh loop (MiTeGen), plunged into liquid nitrogen,
and stored at 70 K.
For p38aK53R in complex with the MKK6 peptide (MKK6KIM-p38aK53R),
protein was incubated overnight at 4C with a 3-fold molar excess of peptide
SKGKKRNPGLKIPKA (Eurogentec). Crystals were obtained as above but
equilibrated against a buffer containing 25% (w/v) PEG 3350 and 0.1 mM
Bis-Tris (pH 6.5). Crystals were transferred to a cryoprotection buffer, pre-
pared as described above (reservoir supplemented with 20% [v/v] PEG 400)
and harvested using a MicroMesh loop, plunged into liquid nitrogen, and
stored at 70 K.
Data Collection and Structure Solution
Diffraction data were collected at beamline ID23-2 (Flot et al., 2010) at the
ESRF (Grenoble, France) on aMAR225 charge-coupled device detector to be-
tween 2.4 and 2.8 A˚ resolution. Crystals of MKK6KIM-p38aK53R formed long
needles (with approximate dimensions of 100 3 20 3 20 mm3) that were diffi-
cult to visualize. Crystals of the GRA24KIM-p38a complex were 500 mm in the
largest dimension and displayed considerable heterogeneity in diffraction
quality (Bowler and Bowler, 2014). Crystals were centered using automated
mesh scans (Bowler et al., 2010; Brockhauser et al., 2012; Gabadinho et al.,
2010; Svensson et al., 2015). The MKK6KIM-p38aK53R complex crystallized
in the trigonal space group P3121, with one molecule in the asymmetric unit
and the GRA24KIM-p38a complex crystallized in the triclinic space group
P1 with two molecules in the asymmetric unit (Table 1). Data were processed
with XDS (Kabsch, 2010) and programs from the Collaborative Computational
Project Number 4 suite (Winn et al., 2011). The structures were solved by
molecular replacement using MolRep (Vagin and Teplyakov, 2010). For the
p38aK53R structure (PDB: 1WFC; Jin et al., 2012) was used as a searchmodelStructure 25, 16–26, January 3, 2017 23
with all water molecules removed. For the p38a and MKK6KIM-p38aK53R
structures, the p38aK53R structure was used as a search model. Refinement
was carried out alternately using Phenix (Afonine et al., 2012) and by manual
rebuilding with COOT (Emsley and Cowtan, 2004). For the GRA24KIM-p38a
complex, tight NCS restraints between monomers in the asymmetric unit
were used at the beginning of refinement. Models were validated using Mol-
Probity (Chen et al., 2010).
SAXS Experiments
SAXS data were collected at the bioSAXS beamline BM29 (Pernot et al., 2013)
at the ESRF with a PILATUS 1 M detector (Dectris) at a wavelength of 0.992 A˚
and a camera length of 2.87 m. Scattering curves were measured from solu-
tions of p38a without substrates, in complex with the GRA24 peptide, and of
the GRA24KIM-p38a complex. Measurements were performed at protein con-
centrations between 2 and 15 mg/mL to verify that any inter-particle effects
that may have been present could be accounted for and rule out their influence
on the analysis. To exclude the possibility of radiation damage, ten frames,
each of 1 s duration, were collected while continuously exposing fresh sam-
ples to the beam, the resulting frames were then compared to ensure that
no differences in the SAXS profiles were induced by exposure to X-rays. All
data were processed using the ATSAS program package (Petoukhov and
Svergun, 2007). Radii of gyration (Rg) were evaluated from Guinier plots using
PRIMUS (Konarev et al., 2003) and pair distance distribution functions, P(r),
were computed with GNOM (Svergun, 1992). The model of the GRA24KIM-
p38a complex was refined using CORAL (Petoukhov et al., 2012).
Electron Microscopy
The GRA24KIM-p38a complex was absorbed to the clean side of a carbon
film on mica, stained with 2% sodium silicotungstate, and transferred to a
400-mesh copper grid. The images were taken under low-dose conditions
(<10 e/A˚2) at a nominal magnification of 49,0003 with defocus values
between 1.2 and 2.5 mm on an FEI Tecnai 12 electron microscope at 120 kV
accelerating voltage using Kodak S0-163 films. Four micrographs were
scanned with a Zeiss scanner at 7 mm pixel size (3.2 A˚ on the sample scale).
Using EMAN2 (Tang et al., 2007), 237 views of the complex were selected,
interactively boxed into 2003 200 pixel boxes. Class averages were produced
using IMAGIC (van Heel et al., 1996).
Atomic Force Microscopy
Samples were adsorbed to mica plates at a concentration of 0.1 mg/mL. A
Chypher AFM (Asylum Research, Oxford Instruments) was used with MSNL
cantilevers (Bruker) in AFM amplitude modulation mode.
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